The Valley Desk

Clinical trial reportJournal for immunotherapy of cancerPublished

DART/SWOG/NCI phase II anti-CTLA-4/PD-1 trial: clear cell carcinomas of ovary, endometrium, cervix

12 of 34 authors shown in byline order.

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Temple University Hospital, with Temple Health linked by the institution reference. Affiliation source

Publication record

Type
Clinical trial report
Venue
Journal for immunotherapy of cancer
Published
Subject terms
Humans; Adenocarcinoma, Clear Cell; Ovarian Neoplasms; Endometrial Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Adult; Aged; Middle Aged; Uterine Cervical Neoplasms; Female; CTLA-4 Antigen; Programmed Cell Death 1 Receptor
PubMed ID
41672597
PubMed Central ID
PMC12911695
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal